Senator Bernie Sanders grills the top executive of Novo Nordisk over high drug prices
The Senate investigation showed Americans pay $1,349 a month for the weight-loss drug Wegovy, which is priced at $92 in the United Kingdom.
Are new frozen meals for weight-loss drugs worth it?
Nestle launched frozen meals tailored for people on weight-loss drugs like Ozempic and Wegovy. We tried the teriyaki chicken ...
WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
WeightWatchers CEO Sima Sistani is leaving the company
The diet and weight-loss brand, which has struggled to adapt in the Ozempic era, is losing its latest chief executive after ...
7 Mistakes People Make While Taking Weight Loss Drugs, According to Experts
GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...
Renal & Urology News3h
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
(HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster ...
BioSpace4h
Lilly Is Not ‘Feeling the Bern’ on Drug Prices Like Novo: Why the Double Standard?
Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...
Sima Sistani, who embraced Ozempic, is out as CEO of WeightWatchers
WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two ...
Sen. Bernie Sanders grills maker of Ozempic
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.
What is 'Ozempic face'? How we refer to weight-loss side effects matters.
The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.
Novo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy?
In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...
Let’s talk about semaglutide — is it safe, and who should consider it?
Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...